MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Clinical trial NCT05735717 · RECRUITING

Trial details

NCT number: NCT05735717
Sponsor: Masonic Cancer Center, University of Minnesota
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hematologic Malignancy Acute Leukemia Remission Acute Myeloid Leukemia Acute Lymphoblastic Leukemia AML TP53 Intrachromosomal Amplification of Chromosome 21 Cytogenetic Abnormality CNS Leukemia Minimal Residual Disease Myelodysplasia

Start date: 2023-05-11
Primary completion: 2027-11-30
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.